Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
16090 Swingley Ridge Road, 355, Chesterfield, MO, 63017, US
Its relocation to a new, dedicated space allows it to better concentrate on its core market—biopharma services.
By: Charlie Sternberg
Timothy Compton of Alcami shares insight on Alcami's role in ensuring a smooth transition from development to manufacturing.
Released By Alcami Corporation
How integrated logistics partners streamline decentralized trials, control costs, and protect ROI.
Released By Yourway Transport, Inc.
AC-201 is being developed to treat multiple immune-mediated inflammatory diseases.
Wendy brings more than 20 years of pharmaceutical quality assurance experience across GLP, GCP and GMP environments.
Parsons will direct compliance strategy, shape operational best practices, enhance regulatory oversight, and mentor future leaders.
Insight on market dynamics driving OSD forms, key development and manufacturing challenges, and the specialized capabilities needed to address them.
By: Ben Locwin
The latest version of its PAS-X Manufacturing Execution System features NextGen cloud and AI support.
CAMCEVI ETM is a long-acting injectable for advanced prostate cancer.
By: Rachel Klemovitch
Will increase global access to AGAMREE for patients with Duchenne muscular dystrophy.
The U.S. Food and Drug Administration (FDA) approved WIDAPLIK on June 6, 2025.
Bayer’s low-dose contrast agent seeks approval for contrast-enhanced MRI of the CNS and other regions for adults and pediatric patients.
Will enhance SGD Pharma’s capabilities and expand its market presence in Europe.
The approval covers the LP.8.1-adapted vaccine, designed to address evolving SARS-CoV-2 sublineages.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
